Who Paid My Doc
Elahere
Drug Oncology
NDC 72903-853-01
General payments
$2,442,944
Research payments
$24,234,399
Through program year 2025, $2,442,944 in general payments and $24,234,399 in research payments were reported against Elahere (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,238,564 | 7,703 |
| 2025 | Research | $14,984,542 | 537 |
| 2024 | General | $1,204,355 | 5,309 |
| 2024 | Research | $8,504,408 | 458 |
| 2023 | General | $25 | 1 |
| 2023 | Research | $745,449 | 60 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 82 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
13,013 general · 1,055 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.